Fingerprint
Dive into the research topics of 'Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR) (Cardiovascular Drugs and Therapy, (2020), 34, 3, (357-370), 10.1007/s10557-019-06919-4)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically